{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T10:29:10Z","timestamp":1795170550800,"version":"4.10.3"},"reference-count":133,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,15]],"date-time":"2022-03-15T00:00:00Z","timestamp":1647302400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,15]],"date-time":"2022-03-15T00:00:00Z","timestamp":1647302400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Heterotypic amyloid interactions between related protein sequences have been observed in functional and disease amyloids. While sequence homology seems to favour heterotypic amyloid interactions, we have no systematic understanding of the structural rules determining such interactions nor whether they inhibit or facilitate amyloid assembly. Using structure-based thermodynamic calculations and extensive experimental validation, we performed a comprehensive exploration of the defining role of sequence promiscuity in amyloid interactions. Using tau as a model system we demonstrate that proteins with local sequence homology to tau amyloid nucleating regions can modify fibril nucleation, morphology, assembly and spreading of aggregates in cultured cells. Depending on the type of mutation such interactions inhibit or promote aggregation in a manner that can be predicted from structure. We find that these heterotypic amyloid interactions can result in the subcellular mis-localisation of these proteins. Moreover, equilibrium studies indicate that the critical concentration of aggregation is altered by heterotypic interactions. Our findings suggest a structural mechanism by which the proteomic background can modulate the aggregation propensity of amyloidogenic proteins and we\u00a0discuss how such sequence-specific proteostatic perturbations could contribute to the selective cellular susceptibility of amyloid disease progression.<\/jats:p>","DOI":"10.1038\/s41467-022-28955-9","type":"journal-article","created":{"date-parts":[[2022,3,15]],"date-time":"2022-03-15T07:03:49Z","timestamp":1647327829000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Mapping the sequence specificity of heterotypic amyloid interactions enables the identification of aggregation modifiers"],"prefix":"10.1038","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4030-1022","authenticated-orcid":false,"given":"Nikolaos","family":"Louros","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meine","family":"Ramakers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emiel","family":"Michiels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0960-6274","authenticated-orcid":false,"given":"Katerina","family":"Konstantoulea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Morelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nele","family":"Moonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0090-3854","authenticated-orcid":false,"given":"Sam","family":"D\u2019Haeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vera","family":"Goossens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1036-1075","authenticated-orcid":false,"given":"Dietmar Rudolf","family":"Thal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Audenaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9189-7399","authenticated-orcid":false,"given":"Frederic","family":"Rousseau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2020-0168","authenticated-orcid":false,"given":"Joost","family":"Schymkowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,15]]},"reference":[{"key":"28955_CR1","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.2174\/1567205013666160502123607","volume":"13","author":"D Van Dam","year":"2016","unstructured":"Van Dam, D., Vermeiren, Y., Dekker, A. D., Naude, P. J. & Deyn, P. P. Neuropsychiatric disturbances in Alzheimer\u2019s Disease: what have we learned from neuropathological studies? Curr. Alzheimer Res. 13, 1145\u20131164 (2016).","journal-title":"Curr. Alzheimer Res."},{"key":"28955_CR2","doi-asserted-by":"publisher","unstructured":"Dugger, B. N. & Dickson, D. W. Pathology of neurodegenerative diseases. Cold Spring Harb. Perspect. Biol. https:\/\/doi.org\/10.1101\/cshperspect.a028035 (2017).","DOI":"10.1101\/cshperspect.a028035"},{"key":"28955_CR3","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1016\/j.cell.2012.02.022","volume":"148","author":"D Eisenberg","year":"2012","unstructured":"Eisenberg, D. & Jucker, M. The amyloid state of proteins in human diseases. Cell 148, 1188\u20131203 (2012).","journal-title":"Cell"},{"key":"28955_CR4","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1146\/annurev-biochem-061516-045115","volume":"86","author":"F Chiti","year":"2017","unstructured":"Chiti, F. & Dobson, C. M. Protein misfolding, amyloid formation, and human disease: a summary of progress over the last decade. Annu. Rev. Biochem. 86, 27\u201368 (2017).","journal-title":"Annu. Rev. Biochem."},{"key":"28955_CR5","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1080\/13506129.2018.1549825","volume":"25","author":"MD Benson","year":"2018","unstructured":"Benson, M. D. et al. Amyloid nomenclature 2018: recommendations by the International Society of Amyloidosis (ISA) nomenclature committee. Amyloid 25, 215\u2013219 (2018).","journal-title":"Amyloid"},{"key":"28955_CR6","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1038\/nrneurol.2013.221","volume":"9","author":"H Braak","year":"2013","unstructured":"Braak, H. et al. Amyotrophic lateral sclerosis-a model of corticofugal axonal spread. Nat. Rev. Neurol. 9, 708\u2013714 (2013).","journal-title":"Nat. Rev. Neurol."},{"key":"28955_CR7","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1146\/annurev-neuro-072116-031153","volume":"40","author":"M Goedert","year":"2017","unstructured":"Goedert, M., Eisenberg, D. S. & Crowther, R. A. Propagation of tau aggregates and neurodegeneration. Annu. Rev. Neurosci. 40, 189\u2013210 (2017).","journal-title":"Annu. Rev. Neurosci."},{"key":"28955_CR8","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s00401-006-0127-z","volume":"112","author":"H Braak","year":"2006","unstructured":"Braak, H., Alafuzoff, I., Arzberger, T., Kretzschmar, H. & Del Tredici, K. Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol. 112, 389\u2013404 (2006).","journal-title":"Acta Neuropathol."},{"key":"28955_CR9","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1038\/s41593-018-0221-2","volume":"21","author":"H Fu","year":"2018","unstructured":"Fu, H., Hardy, J. & Duff, K. E. Selective vulnerability in neurodegenerative diseases. Nat. Neurosci. 21, 1350\u20131358 (2018).","journal-title":"Nat. Neurosci."},{"key":"28955_CR10","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1002\/cne.10760","volume":"463","author":"T Bussiere","year":"2003","unstructured":"Bussiere, T. et al. Progressive degeneration of nonphosphorylated neurofilament protein-enriched pyramidal neurons predicts cognitive impairment in Alzheimer\u2019s disease: stereologic analysis of prefrontal cortex area 9. J. Comp. Neurol. 463, 281\u2013302 (2003).","journal-title":"J. Comp. Neurol."},{"key":"28955_CR11","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1001\/jamaneurol.2017.0263","volume":"74","author":"J Sepulcre","year":"2017","unstructured":"Sepulcre, J. et al. Hierarchical organization of tau and amyloid deposits in the cerebral cortex. JAMA Neurol. 74, 813\u2013820 (2017).","journal-title":"JAMA Neurol."},{"key":"28955_CR12","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1042\/BST20150287","volume":"44","author":"J Hardy","year":"2016","unstructured":"Hardy, J. Catastrophic cliffs: a partial suggestion for selective vulnerability in neurodegenerative diseases. Biochem. Soc. Trans. 44, 659\u2013661 (2016).","journal-title":"Biochem. Soc. Trans."},{"key":"28955_CR13","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/j.neuron.2020.06.010","volume":"107","author":"JP Roussarie","year":"2020","unstructured":"Roussarie, J. P. et al. Selective neuronal vulnerability in Alzheimer\u2019s disease: a network-based analysis. Neuron 107, 821\u2013835.e812 (2020).","journal-title":"Neuron"},{"key":"28955_CR14","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1016\/j.stemcr.2017.10.015","volume":"9","author":"CR Muratore","year":"2017","unstructured":"Muratore, C. R. et al. Cell-type dependent Alzheimer\u2019s disease phenotypes: probing the biology of selective neuronal vulnerability. Stem Cell Rep. 9, 1868\u20131884 (2017).","journal-title":"Stem Cell Rep."},{"key":"28955_CR15","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1007\/s00401-019-02079-9","volume":"138","author":"Z Jaunmuktane","year":"2019","unstructured":"Jaunmuktane, Z. & Brandner, S. On the journey to uncover the causes of selective cellular and regional vulnerability in neurodegeneration. Acta Neuropathol. 138, 677\u2013680 (2019).","journal-title":"Acta Neuropathol."},{"key":"28955_CR16","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1016\/j.ygeno.2018.05.024","volume":"111","author":"S Akila Parvathy Dharshini","year":"2019","unstructured":"Akila Parvathy Dharshini, S., Taguchi, Y. H. & Michael Gromiha, M. Exploring the selective vulnerability in Alzheimer disease using tissue specific variant analysis. Genomics 111, 936\u2013949 (2019).","journal-title":"Genomics"},{"key":"28955_CR17","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/s42003-020-0804-9","volume":"3","author":"A Keo","year":"2020","unstructured":"Keo, A. et al. Transcriptomic signatures of brain regional vulnerability to Parkinson\u2019s disease. Commun. Biol. 3, 101 (2020).","journal-title":"Commun. Biol."},{"key":"28955_CR18","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.neuron.2011.06.031","volume":"71","author":"S Saxena","year":"2011","unstructured":"Saxena, S. & Caroni, P. Selective neuronal vulnerability in neurodegenerative diseases: from stressor thresholds to degeneration. Neuron 71, 35\u201348 (2011).","journal-title":"Neuron"},{"key":"28955_CR19","doi-asserted-by":"publisher","unstructured":"Konstantoulea, K., Louros, N., Rousseau, F. & Schymkowitz, J. Heterotypic interactions in amyloid function and disease. FEBS J. https:\/\/doi.org\/10.1111\/febs.15719 (2021).","DOI":"10.1111\/febs.15719"},{"key":"28955_CR20","doi-asserted-by":"publisher","first-page":"2727","DOI":"10.1523\/JNEUROSCI.3758-06.2007","volume":"27","author":"J Chin","year":"2007","unstructured":"Chin, J. et al. Reelin depletion in the entorhinal cortex of human amyloid precursor protein transgenic mice and humans with Alzheimer\u2019s disease. J. Neurosci. 27, 2727\u20132733 (2007).","journal-title":"J. Neurosci."},{"key":"28955_CR21","doi-asserted-by":"crossref","unstructured":"Pujadas, L. et al. Reelin delays amyloid-beta fibril formation and rescues cognitive deficits in a model of Alzheimer\u2019s disease. Nat. Commun. 5, 3443 (2014).","DOI":"10.1038\/ncomms4443"},{"key":"28955_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/srep31646","volume":"6","author":"I Cuchillo-Ibanez","year":"2016","unstructured":"Cuchillo-Ibanez, I. et al. The beta-amyloid peptide compromises Reelin signaling in Alzheimer\u2019s disease. Sci. Rep. 6, 31646 (2016).","journal-title":"Sci. Rep."},{"key":"28955_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-61777-7","volume":"10","author":"S Banerjee","year":"2020","unstructured":"Banerjee, S., Ferdosh, S., Ghosh, A. N. & Barat, C. Tau protein- induced sequestration of the eukaryotic ribosome: Implications in neurodegenerative disease. Sci. Rep. 10, 5225 (2020).","journal-title":"Sci. Rep."},{"key":"28955_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/srep42017","volume":"7","author":"BK Pathak","year":"2017","unstructured":"Pathak, B. K., Mondal, S., Banerjee, S., Ghosh, A. N. & Barat, C. Sequestration of ribosome during protein aggregate formation: contribution of ribosomal RNA. Sci. Rep. 7, 42017 (2017).","journal-title":"Sci. Rep."},{"key":"28955_CR25","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.neulet.2017.12.003","volume":"672","author":"SA Azizi","year":"2018","unstructured":"Azizi, S. A. & Azizi, S. A. Synucleinopathies in neurodegenerative diseases: accomplices, an inside job and selective vulnerability. Neurosci. Lett. 672, 150\u2013152 (2018).","journal-title":"Neurosci. Lett."},{"key":"28955_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-018-1210-9","volume":"15","author":"I Horvath","year":"2018","unstructured":"Horvath, I. et al. Co-aggregation of pro-inflammatory S100A9 with alpha-synuclein in Parkinson\u2019s disease: ex vivo and in vitro studies. J. Neuroinflammation 15, 172 (2018).","journal-title":"J. Neuroinflammation"},{"key":"28955_CR27","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.tibs.2015.02.003","volume":"40","author":"BJ Ryan","year":"2015","unstructured":"Ryan, B. J., Hoek, S., Fon, E. A. & Wade-Martins, R. Mitochondrial dysfunction and mitophagy in Parkinson\u2019s: from familial to sporadic disease. Trends Biochem Sci. 40, 200\u2013210 (2015).","journal-title":"Trends Biochem Sci."},{"key":"28955_CR28","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.tips.2014.12.004","volume":"36","author":"P Ciryam","year":"2015","unstructured":"Ciryam, P., Kundra, R., Morimoto, R. I., Dobson, C. M. & Vendruscolo, M. Supersaturation is a major driving force for protein aggregation in neurodegenerative diseases. Trends Pharmacol. Sci. 36, 72\u201377 (2015).","journal-title":"Trends Pharmacol. Sci."},{"key":"28955_CR29","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1042\/BST0330578","volume":"33","author":"J Hardy","year":"2005","unstructured":"Hardy, J. Expression of normal sequence pathogenic proteins for neurodegenerative disease contributes to disease risk: \u2018permissive templating\u2019 as a general mechanism underlying neurodegeneration. Biochem. Soc. Trans. 33, 578\u2013581 (2005).","journal-title":"Biochem. Soc. Trans."},{"key":"28955_CR30","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/j.celrep.2013.09.043","volume":"5","author":"P Ciryam","year":"2013","unstructured":"Ciryam, P., Tartaglia, G. G., Morimoto, R. I., Dobson, C. M. & Vendruscolo, M. Widespread aggregation and neurodegenerative diseases are associated with supersaturated proteins. Cell Rep. 5, 781\u2013790 (2013).","journal-title":"Cell Rep."},{"key":"28955_CR31","doi-asserted-by":"publisher","first-page":"e02589","DOI":"10.1016\/j.heliyon.2019.e02589","volume":"5","author":"R Freer","year":"2019","unstructured":"Freer, R. et al. Supersaturated proteins are enriched at synapses and underlie cell and tissue vulnerability in Alzheimer\u2019s disease. Heliyon 5, e02589 (2019).","journal-title":"Heliyon"},{"key":"28955_CR32","doi-asserted-by":"publisher","first-page":"4753","DOI":"10.1073\/pnas.1516604113","volume":"113","author":"P Ciryam","year":"2016","unstructured":"Ciryam, P. et al. A transcriptional signature of Alzheimer\u2019s disease is associated with a metastable subproteome at risk for aggregation. Proc. Natl Acad. Sci. USA 113, 4753\u20134758 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"28955_CR33","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/nature23002","volume":"547","author":"AWP Fitzpatrick","year":"2017","unstructured":"Fitzpatrick, A. W. P. et al. Cryo-EM structures of tau filaments from Alzheimer\u2019s disease. Nature 547, 185\u2013190 (2017).","journal-title":"Nature"},{"key":"28955_CR34","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.sbi.2020.05.011","volume":"64","author":"SH Scheres","year":"2020","unstructured":"Scheres, S. H., Zhang, W., Falcon, B. & Goedert, M. Cryo-EM structures of tau filaments. Curr. Opin. Struct. Biol. 64, 17\u201325 (2020).","journal-title":"Curr. Opin. Struct. Biol."},{"key":"28955_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13564-w","volume":"10","author":"T Strohaker","year":"2019","unstructured":"Strohaker, T. et al. Structural heterogeneity of alpha-synuclein fibrils amplified from patient brain extracts. Nat. Commun. 10, 5535 (2019).","journal-title":"Nat. Commun."},{"key":"28955_CR36","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1111\/joim.12500","volume":"280","author":"M Landreh","year":"2016","unstructured":"Landreh, M. et al. The formation, function and regulation of amyloids: insights from structural biology. J. Intern. Med. 280, 164\u2013176 (2016).","journal-title":"J. Intern. Med."},{"key":"28955_CR37","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/nature20416","volume":"539","author":"R Riek","year":"2016","unstructured":"Riek, R. & Eisenberg, D. S. The activities of amyloids from a structural perspective. Nature 539, 227\u2013235 (2016).","journal-title":"Nature"},{"key":"28955_CR38","doi-asserted-by":"publisher","first-page":"140257","DOI":"10.1016\/j.bbapap.2019.07.010","volume":"1867","author":"L Lutter","year":"2019","unstructured":"Lutter, L., Serpell, C. J., Tuite, M. F. & Xue, W. F. The molecular lifecycle of amyloid - Mechanism of assembly, mesoscopic organisation, polymorphism, suprastructures, and biological consequences. Biochim. Biophys. Acta Proteins Proteom. 1867, 140257 (2019).","journal-title":"Biochim. Biophys. Acta Proteins Proteom."},{"key":"28955_CR39","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.sbi.2019.09.001","volume":"60","author":"R Gallardo","year":"2020","unstructured":"Gallardo, R., Ranson, N. A. & Radford, S. E. Amyloid structures: much more than just a cross-beta fold. Curr. Opin. Struct. Biol. 60, 7\u201316 (2020).","journal-title":"Curr. Opin. Struct. Biol."},{"key":"28955_CR40","doi-asserted-by":"publisher","unstructured":"van der Kant, R., Louros, N., Schymkowitz, J. & Rousseau, F. A structural analysis of amyloid polymorphism in disease: clues for selective vulnerability? bioRxiv https:\/\/doi.org\/10.1101\/2021.03.01.433317 (2021).","DOI":"10.1101\/2021.03.01.433317"},{"key":"28955_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/srep30182","volume":"6","author":"KE Marshall","year":"2016","unstructured":"Marshall, K. E. et al. A critical role for the self-assembly of Amyloid-beta1-42 in neurodegeneration. Sci. Rep. 6, 30182 (2016).","journal-title":"Sci. Rep."},{"key":"28955_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10816","volume":"7","author":"A Ganesan","year":"2016","unstructured":"Ganesan, A. et al. Structural hot spots for the solubility of globular proteins. Nat. Commun. 7, 10816 (2016).","journal-title":"Nat. Commun."},{"key":"28955_CR43","doi-asserted-by":"publisher","first-page":"7258","DOI":"10.1073\/pnas.0308249101","volume":"101","author":"S Ventura","year":"2004","unstructured":"Ventura, S. et al. Short amino acid stretches can mediate amyloid formation in globular proteins: the Src homology 3 (SH3) case. Proc. Natl Acad. Sci. USA 101, 7258\u20137263 (2004).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"28955_CR44","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1093\/protein\/gzp037","volume":"22","author":"PK Teng","year":"2009","unstructured":"Teng, P. K. & Eisenberg, D. Short protein segments can drive a non-fibrillizing protein into the amyloid state. Protein Eng. Des. Sel. 22, 531\u2013536 (2009).","journal-title":"Protein Eng. Des. Sel."},{"key":"28955_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17207-3","volume":"11","author":"N Louros","year":"2020","unstructured":"Louros, N., Orlando, G., De Vleeschouwer, M., Rousseau, F. & Schymkowitz, J. Structure-based machine-guided mapping of amyloid sequence space reveals uncharted sequence clusters with higher solubilities. Nat. Commun. 11, 3314 (2020).","journal-title":"Nat. Commun."},{"key":"28955_CR46","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1021\/ar050069h","volume":"39","author":"R Wetzel","year":"2006","unstructured":"Wetzel, R. Kinetics and thermodynamics of amyloid fibril assembly. Acc. Chem. Res. 39, 671\u2013679 (2006).","journal-title":"Acc. Chem. Res."},{"key":"28955_CR47","doi-asserted-by":"publisher","first-page":"12709","DOI":"10.1021\/bi050927h","volume":"44","author":"B O\u2019Nuallain","year":"2005","unstructured":"O\u2019Nuallain, B., Shivaprasad, S., Kheterpal, I. & Wetzel, R. Thermodynamics of A beta(1-40) amyloid fibril elongation. Biochemistry 44, 12709\u201312718 (2005).","journal-title":"Biochemistry"},{"key":"28955_CR48","doi-asserted-by":"publisher","first-page":"17490","DOI":"10.1074\/jbc.M311300200","volume":"279","author":"B O\u2019Nuallain","year":"2004","unstructured":"O\u2019Nuallain, B., Williams, A. D., Westermark, P. & Wetzel, R. Seeding specificity in amyloid growth induced by heterologous fibrils. J. Biol. Chem. 279, 17490\u201317499 (2004).","journal-title":"J. Biol. Chem."},{"key":"28955_CR49","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1110\/ps.04707004","volume":"13","author":"MR Krebs","year":"2004","unstructured":"Krebs, M. R., Morozova-Roche, L. A., Daniel, K., Robinson, C. V. & Dobson, C. M. Observation of sequence specificity in the seeding of protein amyloid fibrils. Protein Sci. 13, 1933\u20131938 (2004).","journal-title":"Protein Sci."},{"key":"28955_CR50","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/S1097-2765(04)00155-8","volume":"14","author":"DL Vanik","year":"2004","unstructured":"Vanik, D. L., Surewicz, K. A. & Surewicz, W. K. Molecular basis of barriers for interspecies transmissibility of mammalian prions. Mol. Cell 14, 139\u2013145 (2004).","journal-title":"Mol. Cell"},{"key":"28955_CR51","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1126\/science.1082324","volume":"300","author":"BI Giasson","year":"2003","unstructured":"Giasson, B. I. et al. Initiation and synergistic fibrillization of tau and alpha-synuclein. Science 300, 636\u2013640 (2003).","journal-title":"Science"},{"key":"28955_CR52","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/j.ajpath.2014.11.016","volume":"185","author":"ME Oskarsson","year":"2015","unstructured":"Oskarsson, M. E. et al. In vivo seeding and cross-seeding of localized amyloidosis: a molecular link between type 2 diabetes and Alzheimer disease. Am. J. Pathol. 185, 834\u2013846 (2015).","journal-title":"Am. J. Pathol."},{"key":"28955_CR53","doi-asserted-by":"crossref","first-page":"e12130","DOI":"10.1002\/trc2.12130","volume":"7","author":"H Ly","year":"2021","unstructured":"Ly, H. et al. The association of circulating amylin with \u03b2-amyloid in familial Alzheimer\u2019s disease. Alzheimer\u2019s Dement. 7, e12130 (2021).","journal-title":"Alzheimer\u2019s Dement."},{"key":"28955_CR54","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1021\/bi101803k","volume":"50","author":"MI Apostol","year":"2011","unstructured":"Apostol, M. I., Wiltzius, J. J., Sawaya, M. R., Cascio, D. & Eisenberg, D. Atomic structures suggest determinants of transmission barriers in mammalian prion disease. Biochemistry 50, 2456\u20132463 (2011).","journal-title":"Biochemistry"},{"key":"28955_CR55","doi-asserted-by":"publisher","first-page":"2888","DOI":"10.1074\/jbc.M117.806109","volume":"293","author":"P Krotee","year":"2018","unstructured":"Krotee, P. et al. Common fibrillar spines of amyloid-beta and human islet amyloid polypeptide revealed by microelectron diffraction and structure-based inhibitors. J. Biol. Chem. 293, 2888\u20132902 (2018).","journal-title":"J. Biol. Chem."},{"key":"28955_CR56","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s00401-015-1525-x","volume":"131","author":"B Vasconcelos","year":"2016","unstructured":"Vasconcelos, B. et al. Heterotypic seeding of Tau fibrillization by pre-aggregated Abeta provides potent seeds for prion-like seeding and propagation of Tau-pathology in vivo. Acta Neuropathol. 131, 549\u2013569 (2016).","journal-title":"Acta Neuropathol."},{"key":"28955_CR57","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1097\/NEN.0000000000000018","volume":"72","author":"M Colom-Cadena","year":"2013","unstructured":"Colom-Cadena, M. et al. Confluence of alpha-synuclein, tau, and beta-amyloid pathologies in dementia with Lewy bodies. J. Neuropathol. Exp. Neurol. 72, 1203\u20131212 (2013).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"28955_CR58","doi-asserted-by":"publisher","unstructured":"Pham, C. L. et al. Viral M45 and necroptosis-associated proteins form heteromeric amyloid assemblies. EMBO Rep. https:\/\/doi.org\/10.15252\/embr.201846518 (2019).","DOI":"10.15252\/embr.201846518"},{"key":"28955_CR59","doi-asserted-by":"publisher","unstructured":"Sampson, T. R. et al. A gut bacterial amyloid promotes alpha-synuclein aggregation and motor impairment in mice. Elife https:\/\/doi.org\/10.7554\/eLife.53111 (2020).","DOI":"10.7554\/eLife.53111"},{"key":"28955_CR60","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1006\/jmbi.1999.2882","volume":"290","author":"SK Collinson","year":"1999","unstructured":"Collinson, S. K., Parker, J. M., Hodges, R. S. & Kay, W. W. Structural predictions of AgfA, the insoluble fimbrial subunit of Salmonella thin aggregative fimbriae. J. Mol. Biol. 290, 741\u2013756 (1999).","journal-title":"J. Mol. Biol."},{"key":"28955_CR61","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.jsb.2016.05.012","volume":"195","author":"NN Louros","year":"2016","unstructured":"Louros, N. N., Bolas, G. M. P., Tsiolaki, P. L., Hamodrakas, S. J. & Iconomidou, V. A. Intrinsic aggregation propensity of the CsgB nucleator protein is crucial for curli fiber formation. J. Struct. Biol. 195, 179\u2013189 (2016).","journal-title":"J. Struct. Biol."},{"key":"28955_CR62","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1006\/jmbi.2001.4876","volume":"311","author":"AP White","year":"2001","unstructured":"White, A. P. et al. Structure and characterization of AgfB from Salmonella enteritidis thin aggregative fimbriae. J. Mol. Biol. 311, 735\u2013749 (2001).","journal-title":"J. Mol. Biol."},{"key":"28955_CR63","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1002\/1873-3468.12099","volume":"590","author":"NN Louros","year":"2016","unstructured":"Louros, N. N. et al. A common \u2018aggregation-prone\u2019 interface possibly participates in the self-assembly of human zona pellucida proteins. FEBS Lett. 590, 619\u2013630 (2016).","journal-title":"FEBS Lett."},{"key":"28955_CR64","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.cell.2012.06.019","volume":"150","author":"J Li","year":"2012","unstructured":"Li, J. et al. The RIP1\/RIP3 necrosome forms a functional amyloid signaling complex required for programmed necrosis. Cell 150, 339\u2013350 (2012).","journal-title":"Cell"},{"key":"28955_CR65","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1038\/cdd.2014.77","volume":"21","author":"XN Wu","year":"2014","unstructured":"Wu, X. N. et al. Distinct roles of RIP1-RIP3 hetero- and RIP3-RIP3 homo-interaction in mediating necroptosis. Cell Death Differ. 21, 1709\u20131720 (2014).","journal-title":"Cell Death Differ."},{"key":"28955_CR66","doi-asserted-by":"publisher","first-page":"3309","DOI":"10.1016\/j.celrep.2019.08.055","volume":"28","author":"EJ Petrie","year":"2019","unstructured":"Petrie, E. J. et al. Viral MLKL homologs subvert necroptotic cell death by sequestering cellular RIPK3. Cell Rep. 28, 3309\u20133319 e3305 (2019).","journal-title":"Cell Rep."},{"key":"28955_CR67","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/1750-1326-7-56","volume":"7","author":"B Wolozin","year":"2012","unstructured":"Wolozin, B. Regulated protein aggregation: stress granules and neurodegeneration. Mol. Neurodegener. 7, 56 (2012).","journal-title":"Mol. Neurodegener."},{"key":"28955_CR68","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1038\/s41583-019-0222-5","volume":"20","author":"B Wolozin","year":"2019","unstructured":"Wolozin, B. & Ivanov, P. Stress granules and neurodegeneration. Nat. Rev. Neurosci. 20, 649\u2013666 (2019).","journal-title":"Nat. Rev. Neurosci."},{"key":"28955_CR69","doi-asserted-by":"publisher","first-page":"309","DOI":"10.3389\/fncel.2019.00309","volume":"13","author":"C Fabiani","year":"2019","unstructured":"Fabiani, C. & Antollini, S. S. Alzheimer\u2019s disease as a membrane disorder: spatial cross-talk among beta-amyloid peptides, nicotinic acetylcholine receptors and lipid rafts. Front. Cell. Neurosci. 13, 309 (2019).","journal-title":"Front. Cell. Neurosci."},{"key":"28955_CR70","doi-asserted-by":"publisher","first-page":"8328","DOI":"10.1021\/jacs.6b02816","volume":"138","author":"KL Stewart","year":"2016","unstructured":"Stewart, K. L. et al. Atomic details of the interactions of glycosaminoglycans with amyloid-beta fibrils. J. Am. Chem. Soc. 138, 8328\u20138331 (2016).","journal-title":"J. Am. Chem. Soc."},{"key":"28955_CR71","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/nsmb.2971","volume":"22","author":"SIA Cohen","year":"2015","unstructured":"Cohen, S. I. A. et al. A molecular chaperone breaks the catalytic cycle that generates toxic Abeta oligomers. Nat. Struct. Mol. Biol. 22, 207\u2013213 (2015).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"28955_CR72","doi-asserted-by":"publisher","first-page":"12934","DOI":"10.1073\/pnas.0404968101","volume":"101","author":"IL Derkatch","year":"2004","unstructured":"Derkatch, I. L. et al. Effects of Q\/N-rich, polyQ, and non-polyQ amyloids on the de novo formation of the [PSI+] prion in yeast and aggregation of Sup35 in vitro. Proc. Natl Acad. Sci. USA 101, 12934\u201312939 (2004).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"28955_CR73","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1016\/j.cell.2018.03.032","volume":"173","author":"M Mompean","year":"2018","unstructured":"Mompean, M. et al. The structure of the necrosome RIPK1-RIPK3 core, a human hetero-amyloid signaling complex. Cell 173, 1244\u20131253 e1210 (2018).","journal-title":"Cell"},{"key":"28955_CR74","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1021\/acschemneuro.5b00322","volume":"7","author":"A Sidhu","year":"2016","unstructured":"Sidhu, A., Segers-Nolten, I. & Subramaniam, V. Conformational compatibility is essential for heterologous aggregation of alpha-synuclein. ACS Chem. Neurosci. 7, 719\u2013727 (2016).","journal-title":"ACS Chem. Neurosci."},{"key":"28955_CR75","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.jmb.2010.06.053","volume":"402","author":"C Wasmer","year":"2010","unstructured":"Wasmer, C. et al. Structural similarity between the prion domain of HET-s and a homologue can explain amyloid cross-seeding in spite of limited sequence identity. J. Mol. Biol. 402, 311\u2013325 (2010).","journal-title":"J. Mol. Biol."},{"key":"28955_CR76","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1111\/j.1365-2958.2011.07893.x","volume":"82","author":"L Benkemoun","year":"2011","unstructured":"Benkemoun, L. et al. Two structurally similar fungal prions efficiently cross-seed in vivo but form distinct polymers when coexpressed. Mol. Microbiol 82, 1392\u20131405 (2011).","journal-title":"Mol. Microbiol"},{"key":"28955_CR77","doi-asserted-by":"publisher","first-page":"W382","DOI":"10.1093\/nar\/gki387","volume":"33","author":"J Schymkowitz","year":"2005","unstructured":"Schymkowitz, J. et al. The FoldX web server: an online force field. Nucleic Acids Res. 33, W382\u2013W388 (2005).","journal-title":"Nucleic Acids Res."},{"key":"28955_CR78","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-03131-0","volume":"9","author":"L Khodaparast","year":"2018","unstructured":"Khodaparast, L. et al. Aggregating sequences that occur in many proteins constitute weak spots of bacterial proteostasis. Nat. Commun. 9, 866 (2018).","journal-title":"Nat. Commun."},{"key":"28955_CR79","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-16721-8","volume":"11","author":"E Michiels","year":"2020","unstructured":"Michiels, E. et al. Reverse engineering synthetic antiviral amyloids. Nat. Commun. 11, 2832 (2020).","journal-title":"Nat. Commun."},{"key":"28955_CR80","doi-asserted-by":"publisher","first-page":"e102864","DOI":"10.15252\/embj.2019102864","volume":"39","author":"B Houben","year":"2020","unstructured":"Houben, B. et al. Autonomous aggregation suppression by acidic residues explains why chaperones favour basic residues. EMBO J. 39, e102864 (2020).","journal-title":"EMBO J."},{"key":"28955_CR81","doi-asserted-by":"publisher","first-page":"2754","DOI":"10.1073\/pnas.052706099","volume":"99","author":"JS Richardson","year":"2002","unstructured":"Richardson, J. S. & Richardson, D. C. Natural beta-sheet proteins use negative design to avoid edge-to-edge aggregation. Proc. Natl Acad. Sci. USA 99, 2754\u20132759 (2002).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"28955_CR82","doi-asserted-by":"crossref","unstructured":"Banach, M. & Roterman, I. in From Globular Proteins to Amyloids (ed. Roterman-Konieczna, I.) 95\u2013115 (Elsevier, 2020).","DOI":"10.1016\/B978-0-08-102981-7.00010-5"},{"key":"28955_CR83","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S0065-3233(06)73003-0","volume":"73","author":"AV Kajava","year":"2006","unstructured":"Kajava, A. V. & Steven, A. C. Beta-rolls, beta-helices, and other beta-solenoid proteins. Adv. Protein Chem. 73, 55\u201396 (2006).","journal-title":"Adv. Protein Chem."},{"key":"28955_CR84","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s10822-015-9892-x","volume":"30","author":"NN Louros","year":"2016","unstructured":"Louros, N. N., Baltoumas, F. A., Hamodrakas, S. J. & Iconomidou, V. A. A beta-solenoid model of the Pmel17 repeat domain: insights to the formation of functional amyloid fibrils. J. Comput Aided Mol. Des. 30, 153\u2013164 (2016).","journal-title":"J. Comput Aided Mol. Des."},{"key":"28955_CR85","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nature05695","volume":"447","author":"MR Sawaya","year":"2007","unstructured":"Sawaya, M. R. et al. Atomic structures of amyloid cross-beta spines reveal varied steric zippers. Nature 447, 453\u2013457 (2007).","journal-title":"Nature"},{"key":"28955_CR86","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.bbadis.2004.09.010","volume":"1739","author":"M von Bergen","year":"2005","unstructured":"von Bergen, M., Barghorn, S., Biernat, J., Mandelkow, E. M. & Mandelkow, E. Tau aggregation is driven by a transition from random coil to beta sheet structure. Biochim. Biophys. Acta 1739, 158\u2013166 (2005).","journal-title":"Biochim. Biophys. Acta"},{"key":"28955_CR87","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/nchem.2889","volume":"10","author":"PM Seidler","year":"2018","unstructured":"Seidler, P. M. et al. Structure-based inhibitors of tau aggregation. Nat. Chem. 10, 170\u2013176 (2018).","journal-title":"Nat. Chem."},{"key":"28955_CR88","doi-asserted-by":"publisher","first-page":"D389","DOI":"10.1093\/nar\/gkz758","volume":"48","author":"N Louros","year":"2020","unstructured":"Louros, N. et al. WALTZ-DB 2.0: an updated database containing structural information of experimentally determined amyloid-forming peptides. Nucleic Acids Res. 48, D389\u2013D393 (2020).","journal-title":"Nucleic Acids Res."},{"key":"28955_CR89","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/j.ijbiomac.2015.05.032","volume":"79","author":"NN Louros","year":"2015","unstructured":"Louros, N. N. et al. Chameleon \u2018aggregation-prone\u2019 segments of apoA-I: A model of amyloid fibrils formed in apoA-I amyloidosis. Int. J. Biol. Macromol. 79, 711\u2013718 (2015).","journal-title":"Int. J. Biol. Macromol."},{"key":"28955_CR90","doi-asserted-by":"publisher","first-page":"2967","DOI":"10.1021\/acs.biochem.6b00090","volume":"55","author":"LM Blancas-Mejia","year":"2016","unstructured":"Blancas-Mejia, L. M. & Ramirez-Alvarado, M. Recruitment of light chains by homologous and heterologous fibrils shows distinctive kinetic and conformational specificity. Biochemistry 55, 2967\u20132978 (2016).","journal-title":"Biochemistry"},{"key":"28955_CR91","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09033-z","volume":"10","author":"F Liberta","year":"2019","unstructured":"Liberta, F. et al. Cryo-EM fibril structures from systemic AA amyloidosis reveal the species complementarity of pathological amyloids. Nat. Commun. 10, 1104 (2019).","journal-title":"Nat. Commun."},{"key":"28955_CR92","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1038\/s41594-020-0435-3","volume":"27","author":"Q Cao","year":"2020","unstructured":"Cao, Q., Boyer, D. R., Sawaya, M. R., Ge, P. & Eisenberg, D. S. Cryo-EM structure and inhibitor design of human IAPP (amylin) fibrils. Nat. Struct. Mol. Biol. 27, 653\u2013659 (2020).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"28955_CR93","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1038\/s41422-020-0299-4","volume":"30","author":"Y Sun","year":"2020","unstructured":"Sun, Y. et al. Cryo-EM structure of full-length alpha-synuclein amyloid fibril with Parkinson\u2019s disease familial A53T mutation. Cell Res. 30, 360\u2013362 (2020).","journal-title":"Cell Res."},{"key":"28955_CR94","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.str.2014.10.022","volume":"23","author":"NG Sgourakis","year":"2015","unstructured":"Sgourakis, N. G., Yau, W. M. & Qiang, W. Modeling an in-register, parallel \u201ciowa\u201d A\u03b2 fibril structure using solid-state NMR data from labeled samples with rosetta. Structure 23, 216\u2013227 (2015).","journal-title":"Structure"},{"key":"28955_CR95","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1002\/anie.201408598","volume":"54","author":"AK Schutz","year":"2015","unstructured":"Schutz, A. K. et al. Atomic-resolution three-dimensional structure of amyloid beta fibrils bearing the Osaka mutation. Angew. Chem. Int. Ed. Engl. 54, 331\u2013335 (2015).","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"28955_CR96","doi-asserted-by":"publisher","unstructured":"Gallardo, R. et al. Fibril structures of diabetes-related amylin variants reveal a basis for surface-templated assembly. Nat. Struct. Mol. Biolo. https:\/\/doi.org\/10.1038\/s41594-020-0496-3 (2020).","DOI":"10.1038\/s41594-020-0496-3"},{"key":"28955_CR97","doi-asserted-by":"publisher","first-page":"E782","DOI":"10.1073\/pnas.1714966115","volume":"115","author":"C Condello","year":"2018","unstructured":"Condello, C. et al. Structural heterogeneity and intersubject variability of Abeta in familial and sporadic Alzheimer\u2019s disease. Proc. Natl Acad. Sci. USA 115, E782\u2013E791 (2018).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"28955_CR98","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/j.jmb.2013.11.019","volume":"426","author":"K Kar","year":"2014","unstructured":"Kar, K., Arduini, I., Drombosky, K. W., van der Wel, P. C. & Wetzel, R. D-polyglutamine amyloid recruits L-polyglutamine monomers and kills cells. J. Mol. Biol. 426, 816\u2013829 (2014).","journal-title":"J. Mol. Biol."},{"key":"28955_CR99","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1006\/jmbi.2001.5244","volume":"315","author":"A Kapurniotu","year":"2002","unstructured":"Kapurniotu, A., Schmauder, A. & Tenidis, K. Structure-based design and study of non-amyloidogenic, double N-methylated IAPP amyloid core sequences as inhibitors of IAPP amyloid formation and cytotoxicity. J. Mol. Biol. 315, 339\u2013350 (2002).","journal-title":"J. Mol. Biol."},{"key":"28955_CR100","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/j.chembiol.2005.05.010","volume":"12","author":"M Tatarek-Nossol","year":"2005","unstructured":"Tatarek-Nossol, M. et al. Inhibition of hIAPP amyloid-fibril formation and apoptotic cell death by a designed hIAPP amyloid- core-containing hexapeptide. Chem. Biol. 12, 797\u2013809 (2005).","journal-title":"Chem. Biol."},{"key":"28955_CR101","doi-asserted-by":"publisher","first-page":"10378","DOI":"10.1002\/anie.201302840","volume":"52","author":"LM Yan","year":"2013","unstructured":"Yan, L. M. et al. Selectively N-methylated soluble IAPP mimics as potent IAPP receptor agonists and nanomolar inhibitors of cytotoxic self-assembly of both IAPP and Abeta40. Angew. Chem. Int. Ed. Engl. 52, 10378\u201310383 (2013).","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"28955_CR102","doi-asserted-by":"publisher","unstructured":"Sangwan, S. et al. Inhibition of synucleinopathic seeding by rationally designed inhibitors. Elife https:\/\/doi.org\/10.7554\/eLife.46775 (2020).","DOI":"10.7554\/eLife.46775"},{"key":"28955_CR103","doi-asserted-by":"publisher","first-page":"16451","DOI":"10.1074\/jbc.RA119.009688","volume":"294","author":"PM Seidler","year":"2019","unstructured":"Seidler, P. M. et al. Structure-based inhibitors halt prion-like seeding by Alzheimer\u2019s disease-and tauopathy-derived brain tissue samples. J. Biol. Chem. 294, 16451\u201316464 (2019).","journal-title":"J. Biol. Chem."},{"key":"28955_CR104","doi-asserted-by":"publisher","first-page":"6130","DOI":"10.1074\/jbc.RA118.005257","volume":"294","author":"L Saelices","year":"2019","unstructured":"Saelices, L. et al. A pair of peptides inhibits seeding of the hormone transporter transthyretin into amyloid fibrils. J. Biol. Chem. 294, 6130\u20136141 (2019).","journal-title":"J. Biol. Chem."},{"key":"28955_CR105","doi-asserted-by":"publisher","first-page":"54","DOI":"10.3389\/fnmol.2019.00054","volume":"12","author":"J Lu","year":"2019","unstructured":"Lu, J. et al. Structure-based peptide inhibitor design of amyloid-beta aggregation. Front. Mol. Neurosci. 12, 54 (2019).","journal-title":"Front. Mol. Neurosci."},{"key":"28955_CR106","doi-asserted-by":"publisher","unstructured":"Griner, S. L. et al. Structure-based inhibitors of amyloid beta core suggest a common interface with tau. Elife https:\/\/doi.org\/10.7554\/eLife.46924 (2019).","DOI":"10.7554\/eLife.46924"},{"key":"28955_CR107","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1038\/nchem.1433","volume":"4","author":"PN Cheng","year":"2012","unstructured":"Cheng, P. N., Liu, C., Zhao, M., Eisenberg, D. & Nowick, J. S. Amyloid beta-sheet mimics that antagonize protein aggregation and reduce amyloid toxicity. Nat. Chem. 4, 927\u2013933 (2012).","journal-title":"Nat. Chem."},{"key":"28955_CR108","doi-asserted-by":"publisher","unstructured":"Gallardo, R. et al. De novo design of a biologically active amyloid. Science https:\/\/doi.org\/10.1126\/science.aah4949 (2016).","DOI":"10.1126\/science.aah4949"},{"key":"28955_CR109","doi-asserted-by":"publisher","first-page":"E4376","DOI":"10.1073\/pnas.1411649111","volume":"111","author":"BB Holmes","year":"2014","unstructured":"Holmes, B. B. et al. Proteopathic tau seeding predicts tauopathy in vivo. Proc. Natl Acad. Sci. USA 111, E4376\u2013E4385 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"28955_CR110","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1126\/science.abb8032","volume":"370","author":"C Mathieu","year":"2020","unstructured":"Mathieu, C., Pappu, R. V. & Taylor, J. P. Beyond aggregation: pathological phase transitions in neurodegenerative disease. Science 370, 56\u201360 (2020).","journal-title":"Science"},{"key":"28955_CR111","doi-asserted-by":"publisher","DOI":"10.1038\/srep30498","volume":"6","author":"CA Brunello","year":"2016","unstructured":"Brunello, C. A., Yan, X. & Huttunen, H. J. Internalized Tau sensitizes cells to stress by promoting formation and stability of stress granules. Sci. Rep. 6, 30498 (2016).","journal-title":"Sci. Rep."},{"key":"28955_CR112","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09902-7","volume":"10","author":"X Gui","year":"2019","unstructured":"Gui, X. et al. Structural basis for reversible amyloids of hnRNPA1 elucidates their role in stress granule assembly. Nat. Commun. 10, 2006 (2019).","journal-title":"Nat. Commun."},{"key":"28955_CR113","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1038\/s41557-020-0465-9","volume":"12","author":"S Ray","year":"2020","unstructured":"Ray, S. et al. alpha-Synuclein aggregation nucleates through liquid-liquid phase separation. Nat. Chem. 12, 705\u2013716 (2020).","journal-title":"Nat. Chem."},{"key":"28955_CR114","doi-asserted-by":"publisher","first-page":"891","DOI":"10.3233\/JAD-150379","volume":"48","author":"NK Jha","year":"2015","unstructured":"Jha, N. K. et al. Impact of insulin degrading enzyme and neprilysin in alzheimer\u2019s disease biology: characterization of putative cognates for therapeutic applications. J. Alzheimers Dis. 48, 891\u2013917 (2015).","journal-title":"J. Alzheimers Dis."},{"key":"28955_CR115","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.tips.2017.10.008","volume":"39","author":"IV Kurochkin","year":"2018","unstructured":"Kurochkin, I. V., Guarnera, E. & Berezovsky, I. N. Insulin-degrading enzyme in the fight against Alzheimer\u2019s disease. Trends Pharmacol. Sci. 39, 49\u201358 (2018).","journal-title":"Trends Pharmacol. Sci."},{"key":"28955_CR116","doi-asserted-by":"publisher","first-page":"166993","DOI":"10.1016\/j.jmb.2021.166993","volume":"433","author":"BR Sahoo","year":"2021","unstructured":"Sahoo, B. R. et al. Degradation of Alzheimer\u2019s amyloid-beta by a catalytically inactive insulin-degrading enzyme. J. Mol. Biol. 433, 166993 (2021).","journal-title":"J. Mol. Biol."},{"key":"28955_CR117","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1016\/S0002-9440(10)63005-2","volume":"159","author":"Q Chen","year":"2001","unstructured":"Chen, Q. et al. Presenilin binding protein is associated with neurofibrillary alterations in Alzheimer\u2019s disease and stimulates tau phosphorylation. Am. J. Pathol. 159, 1597\u20131602 (2001).","journal-title":"Am. J. Pathol."},{"key":"28955_CR118","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/jnc.13069","volume":"133","author":"XY Liu","year":"2015","unstructured":"Liu, X. Y. et al. Regulation of RAGE splicing by hnRNP A1 and Tra2beta-1 and its potential role in AD pathogenesis. J. Neurochem. 133, 187\u2013198 (2015).","journal-title":"J. Neurochem."},{"key":"28955_CR119","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1159\/000348406","volume":"3","author":"J Wong","year":"2013","unstructured":"Wong, J. Altered expression of RNA splicing proteins in Alzheimer\u2019s disease patients: evidence from two microarray studies. Dement Geriatr. Cogn. Dis. Extra 3, 74\u201385 (2013).","journal-title":"Dement Geriatr. Cogn. Dis. Extra"},{"key":"28955_CR120","doi-asserted-by":"publisher","first-page":"e89020","DOI":"10.1371\/journal.pone.0089020","volume":"9","author":"M Storbeck","year":"2014","unstructured":"Storbeck, M. et al. Neuronal-specific deficiency of the splicing factor Tra2b causes apoptosis in neurogenic areas of the developing mouse brain. PLoS ONE 9, e89020 (2014).","journal-title":"PLoS ONE"},{"key":"28955_CR121","doi-asserted-by":"publisher","unstructured":"Lester, E. et al. Tau aggregates are RNA-protein assemblies that mislocalize multiple nuclear speckle components. Neuron https:\/\/doi.org\/10.1016\/j.neuron.2021.03.026 (2021).","DOI":"10.1016\/j.neuron.2021.03.026"},{"key":"28955_CR122","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s13195-016-0208-8","volume":"8","author":"A \u00d6hrfelt","year":"2016","unstructured":"\u00d6hrfelt, A. et al. The pre-synaptic vesicle protein synaptotagmin is a novel biomarker for Alzheimer\u2019s disease. Alzheimer\u2019s Res. Ther. 8, 41 (2016).","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"28955_CR123","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.neurobiolaging.2019.10.006","volume":"86","author":"LJ Keller","year":"2020","unstructured":"Keller, L. J. et al. Presenilin 1 increases association with synaptotagmin 1 during normal aging. Neurobiol. Aging 86, 156\u2013161 (2020).","journal-title":"Neurobiol. Aging"},{"key":"28955_CR124","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-017-0159-y","volume":"12","author":"KM Zoltowska","year":"2017","unstructured":"Zoltowska, K. M. et al. Dynamic presenilin 1 and synaptotagmin 1 interaction modulates exocytosis and amyloid \u03b2 production. Mol. Neurodegener. 12, 15 (2017).","journal-title":"Mol. Neurodegener."},{"key":"28955_CR125","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1002\/ana.25481","volume":"85","author":"S Iwasawa","year":"2019","unstructured":"Iwasawa, S. et al. Recurrent de novo MAPK8IP3 variants cause neurological phenotypes. Ann. Neurol. 85, 927\u2013933 (2019).","journal-title":"Ann. Neurol."},{"key":"28955_CR126","doi-asserted-by":"publisher","unstructured":"Gowrishankar, S. et al. Overlapping roles of JIP3 and JIP4 in promoting axonal transport of lysosomes in human iPSC-derived neurons. bioRxiv https:\/\/doi.org\/10.1101\/2020.06.13.149443 (2021).","DOI":"10.1101\/2020.06.13.149443"},{"key":"28955_CR127","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1093\/nar\/28.1.235","volume":"28","author":"HM Berman","year":"2000","unstructured":"Berman, H. M. et al. The Protein Data Bank. Nucleic Acids Res. 28, 235\u2013242 (2000).","journal-title":"Nucleic Acids Res."},{"key":"28955_CR128","doi-asserted-by":"publisher","first-page":"e80635","DOI":"10.1371\/journal.pone.0080635","volume":"8","author":"MZ Tien","year":"2013","unstructured":"Tien, M. Z., Meyer, A. G., Sydykova, D. K., Spielman, S. J. & Wilke, C. O. Maximum allowed solvent accessibilites of residues in proteins. PLoS ONE 8, e80635 (2013).","journal-title":"PLoS ONE"},{"key":"28955_CR129","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s008940050118","volume":"5","author":"P Tao","year":"1999","unstructured":"Tao, P., Wang, R. & Lai, L. Calculating partition coefficients of peptides by the addition method. Mol. Modeling Annu. 5, 189\u2013195 (1999).","journal-title":"Mol. Modeling Annu."},{"key":"28955_CR130","first-page":"45","volume":"47","author":"PY Chou","year":"1978","unstructured":"Chou, P. Y. & Fasman, G. D. Prediction of the secondary structure of proteins from their amino acid sequence. Adv. Enzymol. Relat. Areas Mol. Biol. 47, 45\u2013148 (1978).","journal-title":"Adv. Enzymol. Relat. Areas Mol. Biol."},{"key":"28955_CR131","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1021\/ac60214a047","volume":"36","author":"A Savitzky","year":"1964","unstructured":"Savitzky, A. & Golay, M. J. E. Smoothing and differentiation of data by simplified least squares procedures. Anal. Chem. 36, 1627\u20131639 (1964).","journal-title":"Anal. Chem."},{"key":"28955_CR132","doi-asserted-by":"publisher","unstructured":"Mirbaha, H. et al. Inert and seed-competent tau monomers suggest structural origins of aggregation. Elife https:\/\/doi.org\/10.7554\/eLife.36584 (2018).","DOI":"10.7554\/eLife.36584"},{"key":"28955_CR133","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/0896-6273(92)90117-V","volume":"8","author":"M Goedert","year":"1992","unstructured":"Goedert, M., Spillantini, M. G., Cairns, N. J. & Crowther, R. A. Tau proteins of Alzheimer paired helical filaments: abnormal phosphorylation of all six brain isoforms. Neuron 8, 159\u2013168 (1992).","journal-title":"Neuron"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-28955-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-28955-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-28955-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T16:17:57Z","timestamp":1700324277000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-28955-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,15]]},"references-count":133,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["28955"],"URL":"https:\/\/doi.org\/10.1038\/s41467-022-28955-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.06.04.447096","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,15]]},"assertion":[{"value":"11 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"N.L., E.M., J.S. and F.R. are listed as inventors of a patent held by their hold institution VIB (patent application number - WO2021229102), covering the methodology described in this manuscript for the development of structure-based amyloid inhibitors. D.R.T. received speaker honorarium from Novartis Pharma Basel (Switzerland) and Biogen (USA), travel reimbursement from GE-Healthcare (UK), and UCB (Belgium), and collaborated with GE-Healthcare (UK), Novartis Pharma Basel (Switzerland), Probiodrug (Germany) and Janssen Pharmaceutical Companies (Belgium). The other authors declare no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1351"}}